Equisights Research (“Equisights”) is a distinguished independent sell-side research firm that excels in delivering in-depth, objective analysis and strategic insights. Our research efforts are primarily centered on the U.S. markets, with a strong sectoral emphasis on Technology, Media, and Telecommunications (TMT), healthcare, consumer cyclicals & non-cyclicals, industrials, energy, and select financials. Equisights serves to several notable buy-side funds, RIAs, family offices, and over 1,000 institutional relationships, who take positions across our coverage universe and manage portfolios ranging from $100 million to $1 billion in assets.
Our comprehensive research framework involves an in-depth analysis of each company’s growth potential, financial health, management quality, industry position, risk factors, and valuation. Our recommendations and ratings process is based on gathering and interpreting data, drawing conclusions, and evaluating these factors to determine final ratings based on intrinsic value, expected growth, and risks. Equisights maintains its independence by not participating in public offerings, advising on mergers and acquisitions, brokering trades, making markets in stocks, or managing money.
RESEARCH FEED : OUR PERSPECTIVE
- Airbnb stock soars 9% on earnings and revenue beat, strong guidance for third quarter
- Airbnb stock soars 12% on earnings and revenue beat, strong guidance for third quarter
- Versant raises 2026 outlook on strength of platforms segment and advertising momentum
- Grindr's AI spend is paying off and its pricey new tier has had some surprises, CEO says
- Savers Value Village thrift store launches new AI tool to price items
- Fox advertising, streaming service Tubi get boost from World Cup
- Stocks making the biggest moves after hours: Twilio, Airbnb, DraftKings, Trade Desk and more
- Copper jumps to its highest level ever. What the metal is telling us
- United Wholesale Mortgage plunges 40% after suspending dividend and raising capital
- Traders on Kalshi now think it's likely that the S&P 500 will hit 8,000 in 2026
- Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
- Stocks making the biggest moves premarket: Zillow, Peloton, Sandisk, Moderna & more
- Device maker Stryker strikes $4.9 billion deal for Inari Medical
- Despite revamped proposals, Nippon Steel deal on track to be blocked, letter shows
- Rosneft, Reliance agree biggest ever India-Russia oil supply deal
- Worldline attracts early stage interest from private equity firms
- India’s Andhra Pradesh state likely to suspend Adani power deal
- Sony is in talks to buy media powerhouse behind ‘Elden Ring’

